Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19
OBJECTIVES: Cancer patients have worse outcomes from the COVID-19 infection and greater need for ventilator support and elevated mortality rates than the general population. However, previous artificial intelligence (AI) studies focused on patients without cancer to develop diagnosis and severity prediction models. Little is known about how the AI models perform in cancer patients. In this study, we aim to develop a computational framework for COVID-19 diagnosis and severity prediction particularly in a cancer population and further compare it head-to-head to a general population.
METHODS: We have enrolled multi-center international cohorts with 531 CT scans from 502 general patients and 420 CT scans from 414 cancer patients. In particular, the habitat imaging pipeline was developed to quantify the complex infection patterns by partitioning the whole lung regions into phenotypically different subregions. Subsequently, various machine learning models nested with feature selection were built for COVID-19 detection and severity prediction.
RESULTS: These models showed almost perfect performance in COVID-19 infection diagnosis and predicting its severity during cross validation. Our analysis revealed that models built separately on the cancer population performed significantly better than those built on the general population and locked to test on the cancer population. This may be because of the significant difference among the habitat features across the two different cohorts.
CONCLUSIONS: Taken together, our habitat imaging analysis as a proof-of-concept study has highlighted the unique radiologic features of cancer patients and demonstrated effectiveness of CT-based machine learning model in informing COVID-19 management in the cancer population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Cancers - 15(2022), 1 vom: 31. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aminu, Muhammad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 06.07.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/cancers15010275 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351233695 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351233695 | ||
| 003 | DE-627 | ||
| 005 | 20231226050852.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers15010275 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1170.xml |
| 035 | |a (DE-627)NLM351233695 | ||
| 035 | |a (NLM)36612278 | ||
| 035 | |a (PII)275 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Aminu, Muhammad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.07.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a OBJECTIVES: Cancer patients have worse outcomes from the COVID-19 infection and greater need for ventilator support and elevated mortality rates than the general population. However, previous artificial intelligence (AI) studies focused on patients without cancer to develop diagnosis and severity prediction models. Little is known about how the AI models perform in cancer patients. In this study, we aim to develop a computational framework for COVID-19 diagnosis and severity prediction particularly in a cancer population and further compare it head-to-head to a general population | ||
| 520 | |a METHODS: We have enrolled multi-center international cohorts with 531 CT scans from 502 general patients and 420 CT scans from 414 cancer patients. In particular, the habitat imaging pipeline was developed to quantify the complex infection patterns by partitioning the whole lung regions into phenotypically different subregions. Subsequently, various machine learning models nested with feature selection were built for COVID-19 detection and severity prediction | ||
| 520 | |a RESULTS: These models showed almost perfect performance in COVID-19 infection diagnosis and predicting its severity during cross validation. Our analysis revealed that models built separately on the cancer population performed significantly better than those built on the general population and locked to test on the cancer population. This may be because of the significant difference among the habitat features across the two different cohorts | ||
| 520 | |a CONCLUSIONS: Taken together, our habitat imaging analysis as a proof-of-concept study has highlighted the unique radiologic features of cancer patients and demonstrated effectiveness of CT-based machine learning model in informing COVID-19 management in the cancer population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a habitat imaging | |
| 650 | 4 | |a machine learning | |
| 650 | 4 | |a prognosis | |
| 700 | 1 | |a Yadav, Divya |e verfasserin |4 aut | |
| 700 | 1 | |a Hong, Lingzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Young, Elliana |e verfasserin |4 aut | |
| 700 | 1 | |a Edelkamp, Paul |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Saad, Maliazurina |e verfasserin |4 aut | |
| 700 | 1 | |a Salehjahromi, Morteza |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Pingjun |e verfasserin |4 aut | |
| 700 | 1 | |a Sujit, Sheeba J |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Melissa M |e verfasserin |4 aut | |
| 700 | 1 | |a Sabloff, Bradley |e verfasserin |4 aut | |
| 700 | 1 | |a Gladish, Gregory |e verfasserin |4 aut | |
| 700 | 1 | |a de Groot, Patricia M |e verfasserin |4 aut | |
| 700 | 1 | |a Godoy, Myrna C B |e verfasserin |4 aut | |
| 700 | 1 | |a Cascone, Tina |e verfasserin |4 aut | |
| 700 | 1 | |a Vokes, Natalie I |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jianjun |e verfasserin |4 aut | |
| 700 | 1 | |a Brock, Kristy K |e verfasserin |4 aut | |
| 700 | 1 | |a Daver, Naval |e verfasserin |4 aut | |
| 700 | 1 | |a Woodman, Scott E |e verfasserin |4 aut | |
| 700 | 1 | |a Tawbi, Hussein A |e verfasserin |4 aut | |
| 700 | 1 | |a Sheshadri, Ajay |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, J Jack |e verfasserin |4 aut | |
| 700 | 1 | |a Jaffray, David |e verfasserin |4 aut | |
| 700 | 1 | |a D Code Team |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Carol C |e verfasserin |4 aut | |
| 700 | 1 | |a Chung, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Jia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d 2009 |g 15(2022), 1 vom: 31. Dez. |w (DE-627)NLM198667213 |x 2072-6694 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2022 |g number:1 |g day:31 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/cancers15010275 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2022 |e 1 |b 31 |c 12 | ||